Manolis Papagiannakis

Manolis Papagiannakis is a MedTech expert with nearly 20 years of experience in the development, validation and commercialisation of innovative medical technologies. He supports early-stage startups to build compliant, high-quality products, providing strategic guidance and hands-on support in product development, quality management, regulatory compliance and clinical validation, with particular focus on software-driven applications. He aspires to help founders bring to market innovative, safe and effective medical devices.

Previously, Manolis served as Senior Clinical Director at DYSIS Medical, a spin-off from FORTH, that developed and commercialised disruptive imaging technology for cervical cancer prevention. Over 19 years, he experienced the full startup cycle, from early R&D to international commercialisation, with leadership roles in various aspects of the business, including technology and software development, clinical strategy and operations, regulatory affairs and market access. He led cross-functional teams, managed international clinical studies and established research collaborations that resulted in patents and scientific publications.

Manolis holds a PhD in Biophysics from Vrije Universiteit Amsterdam and a BSc in Physics from the University of Crete.